Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03971955 · ClinicalTrials.gov registry record

CharacterIzation of Adult Onset Autoimmune Diabetes

A clinical trial of Diabetes, sponsored by AdventHealth Translational Research Institute.

Active
Registry status
25
Enrollment target
1
Study location

NCT03971955 is a study of Diabetes that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 25 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03971955, a study of Diabetes, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.

ACTIVE NOT RECRUITING
Registry status
25 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to identify new biomarkers of Adult Onset Autoimmune Diabetes (AOnAD).

Conditions Studied

Interventions

  • PROCEDURE Adipose Tissue Biopsy
  • OTHER Mixed Meal Test
  • OTHER Dual Energy X-Ray Absorptiometry (DEXA)

Study Locations (1)

Florida

  • Translational Research Institute for Metabolism and Diabetes - Orlando

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2019-07-08
Est. Completion 2025-12

What the Registry Record Tells You About NCT03971955

The ClinicalTrials.gov registry entry for NCT03971955 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Adipose Tissue Biopsy is the first listed.

NCT03971955 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03971955 about?

NCT03971955 is a clinical study titled "CharacterIzation of Adult Onset Autoimmune Diabetes". The purpose of the study is to identify new biomarkers of Adult Onset Autoimmune Diabetes (AOnAD).

What is the current status of trial NCT03971955?

This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2019-07-08. Estimated completion is 2025-12.

What conditions does trial NCT03971955 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT03971955?

The interventions under investigation include: Adipose Tissue Biopsy (PROCEDURE), Mixed Meal Test (OTHER), Dual Energy X-Ray Absorptiometry (DEXA) (OTHER).

Who is sponsoring clinical trial NCT03971955?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03971955 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.